Treatment for Osteoarthritis Knee Pain

Treatment options for OA knee pain

The goals of treatment

  • Controlling pain and other symptoms
  • Improving patient ability to function in daily activities23
Treatments include:

Non-drug treatments
  • Joint protection (avoiding activities that cause joint pain/damage)
  • Exercise
  • Physical therapy
  • Weight loss23
Non-prescription medication
  • Painkillers such as acetaminophen
  • Aspirin and other nonsteroidal anti-inflammatory agents (NSAIDs) such as ibuprofen and naproxen19
Prescription medications
  • COX-2 inhibitors such as Celebrex® and Mobic®
  • Steroid injections
  • Pain relievers such as narcotics (Percocet®) and Ultracet®19
Hyaluronate treatment

Another alternative is to treat the pain of osteoarthritis of the knee with hyaluronate injections. Hyaluronate is a natural substance found in high amounts in the synovial fluid of normal, healthy joints. When injected into a knee with OA, hyaluronate acts like a lubricant and shock absorber.21 Several different hyaluronate products are available for medical use, including HYALGAN®.

Surgery

Knee surgery may be an option for people who cannot obtain relief of knee pain in a less invasive mannner.19

Brands listed are the registered trademarks of their respective owners.


Important Safety Information for HYALGAN®

  • HYALGAN® is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative nonpha-rmacologic therapy, and to simple analgesics, eg, acetaminophen
  • HYALGAN® is contraindicated in patients with known hypersensitivity to hyaluronate preparations. Intra-articular injections are contraindicated in cases of past and present infections or skin diseases in the area of the injection site
  • The effectiveness of a single treatment cycle of less than 3 injections has not been established
  • In the US clinical trial of 495 patients, the only adverse event showing statistical significance vs placebo was injection-site pain
  • Other adverse events included gastrointestinal complaints, headache, local ecchymosis and rash, local joint pain and swelling, and local pruritus. However, the incidence of these events was similar in the HYALGAN®-treated and placebo groups
  • In other clinical studies, the frequency and severity of adverse events occurring during repeat treatment cycles did not increase over that reported for a single treatment cycle

Click here for additional important information for HYALGAN®.